Skip to main content
Premium Trial:

Request an Annual Quote

Todos Medical Obtains $3.4M Investment From Yozma Group Korea

NEW YORK ─ Todos Medical on Monday announced a $3.4 million strategic investment in its business by venture capital firm Yozma Group Korea.

Under the terms of the agreement, Yozma has been issued a one-year, $3.4 million promissory note convertible into common shares at a fixed price of $0.0599 per share, Todos said.

Rehovot, Israel-based Todos said it intends to use the proceeds for general working capital, to retire outstanding convertible notes, and to complete the acquisition of proteomics test developer Provista Diagnostics.

Todos announced more than a year ago that it had entered into an exclusive option agreement to acquire Provista.

Todos is a developer of in vitro diagnostic tests for the detection of cancers and neurodegenerative diseases and has inked agreements to distribute SARS-CoV-2 test kits including PCR- and antibody-based tests. 

South Korea-based Yozma said in a statement that it sees a "significant opportunity" to fuel Todos' growth with an infusion of capital as it adds "complementary products" to an expanding sales pipeline.

Further, Yozma added that it sees an opportunity to help drive cross-border collaboration for Todos in South Korea.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.